According to a study conducted by the Tufts Center for the Study of Drug Development, the average study activation time is a full month longer than it was 10 years ago. While there are a number of factors that contributed to the increase, including a higher number of new site initiations and increased trial complexity, this eye-opening statistic makes it clear that delayed study start-up is a chronic problem in the research industry.
Over the years, the industry has worked to find a way to streamline the study start-up process through best practices, technology and services. However, improving processes during study activation is only part of the solution. Relationships between stakeholders, particularly clinical research sites and sponsors, are incredibly influential to expedited study activation and poor communication can lead to delays both during start-up and later in the study. In this infographic, we examine how both sites and sponsors can improve communication and organizational practices in three key areas: enrollment estimates, feasibility questionnaires and protocol complexity.
You can also download our free eBook Improving Site-Sponsor Relationships: Proactive Strategies for Transparent Clinical Trials to learn more steps sites and sponsors can take to improve relationships and speed up study timelines.
Streamlining study activation begins by ensuring all involved stakeholders have the tools and information they need to perform critical start-up tasks. Download your copy of the free eBook Improving Site-Sponsor Relationships: Proactive Strategies for Transparent Clinical Trials to learn more steps sites and sponsors can take to improve relationships and speed up study timelines.